# A Phase I/II Study of the Safety and Efficacy of Sernova's Cell PouchTM for Therapeutic Islet Transplantation

> **NCT01652911** · PHASE1,PHASE2 · TERMINATED · sponsor: **University of Alberta** · enrollment: 3 (actual)

## Conditions studied

- Type I Diabetes

## Interventions

- **DEVICE:** Sernova Cell Pouch

## Key facts

- **NCT ID:** NCT01652911
- **Lead sponsor:** University of Alberta
- **Sponsor class:** OTHER
- **Phase:** PHASE1,PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2012-06
- **Primary completion:** 2016-03
- **Final completion:** 2016-03
- **Target enrollment:** 3 (ACTUAL)
- **Last updated:** 2022-05-11

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01652911

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01652911, "A Phase I/II Study of the Safety and Efficacy of Sernova's Cell PouchTM for Therapeutic Islet Transplantation". Retrieved via AI Analytics 2026-06-24 from https://api.ai-analytics.org/clinical/NCT01652911. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*